Paper31369045
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
Garcia-Murillas I and 21 others. JAMA Oncol, 2019. Cited by 351 papers, by iCite.
Cite this record
ConductScience Library. Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer. Papers, record 31369045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31369045
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Circulating Tumor DNA | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Adult | |
| Aged | |
| Biomarkers, Tumor | |
| Female | |
| Humans | |
| Middle Aged | |
| Mutation | |
| Recurrence |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 25351 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04985266 | A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer | Background | ClinicalTrials.gov | |
| NCT05058183 | Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer | Background | ClinicalTrials.gov |
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 31917389 | Errors in Results. | https://conductscience.org/library/papers/31917389 | PubMed |
| Comment in | 31855227 | Clinical Benefit of Circulating Tumor DNA Analysis in Early-Stage Breast Cancer. | https://conductscience.org/library/papers/31855227 | PubMed |
| Comment in | 31855255 | Clinical Benefit of Circulating Tumor DNA Analysis in Follow-up of Patients With Early-Stage Breast Cancer-Reply. | https://conductscience.org/library/papers/31855255 | PubMed |
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29601269 | Molecular Minimal Residual Disease in Acute Myeloid Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29601269 | PubMed |
| 2 | 26311728 | Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26311728 | PubMed |
| 3 | 26789727 | Assessment of Minimal Residual Disease in Standard-Risk AML. | N Engl J Med | 2016 | https://conductscience.org/library/papers/26789727 | PubMed |
| 4 | 29504847 | Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29504847 | PubMed |
| 5 | 29567812 | False-Positive Plasma Genotyping Due to Clonal Hematopoiesis. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29567812 | PubMed |
| 6 | 25326804 | Age-related mutations associated with clonal hematopoietic expansion and malignancies. | Nat Med | 2014 | https://conductscience.org/library/papers/25326804 | PubMed |
| 7 | 28445469 | Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. | Nature | 2017 | https://conductscience.org/library/papers/28445469 | PubMed |
| 8 | 25654990 | Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. | Gut | 2016 | https://conductscience.org/library/papers/25654990 | PubMed |
| 9 | 25426838 | Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25426838 | PubMed |
| 10 | 28899864 | Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. | Cancer Discov | 2017 | https://conductscience.org/library/papers/28899864 | PubMed |
| 11 | 26554728 | Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. | Nat Commun | 2015 | https://conductscience.org/library/papers/26554728 | PubMed |
| 12 | 27384348 | Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/27384348 | PubMed |
| 13 | 25987569 | Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. | EMBO Mol Med | 2015 | https://conductscience.org/library/papers/25987569 | PubMed |
| 14 | 24627271 | Promoting quality and evidence-based care in early-stage breast cancer follow-up. | J Natl Cancer Inst | 2014 | https://conductscience.org/library/papers/24627271 | PubMed |
| 15 | 24553385 | Detection of circulating tumor DNA in early- and late-stage human malignancies. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24553385 | PubMed |
Cited by234
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 351 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958365 | Dynamic ctDNA-MRD in breast cancer: subtype-specific implications for perioperative decision-making, postoperative surveillance, and MRD-guided therapy. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42958365 | PubMed |
| 42938935 | Clinical Challenges in Triple-Negative Breast Cancer (TNBC): Current Treatment Options, Their Limitations, and Emerging Perspectives. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938935 | PubMed |
| 42911423 | The right patient, the right moment, the right therapy: reimagining precision oncology from the bedside. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42911423 | PubMed |
| 42724567 | Assessing the utility of ctDNA as a prognostic marker in advanced ER-positive/HER2-negative breast cancer. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724567 | PubMed |
| 42645355 | Evolution of the Use of Circulating DNA as a Biomarker in Neoadjuvant Therapy of Breast Cancer. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42645355 | PubMed |
| 42582727 | Current perspectives on circulating tumor DNA in breast cancer: a narrative review. | Transl Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42582727 | PubMed |
| 42558411 | Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42558411 | PubMed |
| 42508231 | Common analysis pitfalls in longitudinal ctDNA studies: lead time, sensitivity and immortal time bias. | EBioMedicine | 2026 | https://conductscience.org/library/papers/42508231 | PubMed |
| 42504045 | Applications of Artificial Intelligence in Cancer Diagnosis and Treatment. | Cancer Med | 2026 | https://conductscience.org/library/papers/42504045 | PubMed |
| 42472109 | The role of serologic biomarkers "liquid biopsy" in the fight against breast cancer: From biological foundations to clinical impact. | iScience | 2026 | https://conductscience.org/library/papers/42472109 | PubMed |
| 42430497 | A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing. | Sci Adv | 2026 | https://conductscience.org/library/papers/42430497 | PubMed |
| 42421646 | Circulating tumor DNA in early breast cancer: Evidence, challenges, next steps. | Cancer | 2026 | https://conductscience.org/library/papers/42421646 | PubMed |
| 42401541 | Unlocking the ferroptotic window: Lipidomic rewiring and metabolic addiction in EMT-driven breast cancer resistance. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42401541 | PubMed |
| 42324681 | Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast. | Future Oncol | 2026 | https://conductscience.org/library/papers/42324681 | PubMed |
| 42299414 | The complete treatment and management of brain metastases in a patient with limited-stage small cell lung cancer under molecular residual disease (MRD) monitoring: a case report. | AME Case Rep | 2026 | https://conductscience.org/library/papers/42299414 | PubMed |
| 42250175 | Integrating multi-omics and clinical management in breast cancer: a comprehensive review. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42250175 | PubMed |
| 42242004 | Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial. | ESMO Open | 2026 | https://conductscience.org/library/papers/42242004 | PubMed |
| 42161983 | Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/42161983 | PubMed |
| 42016861 | Microfluidic approaches for liquid biopsy in glioblastoma: Insights into diagnostic and follow-up strategies. | Bioeng Transl Med | 2026 | https://conductscience.org/library/papers/42016861 | PubMed |
| 42003932 | Biological basis and clinical translation prospects of circulating cell-free DNA in precision management of breast cancer (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42003932 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31369045
GET https://conductscience.org/api/papers/v1/31369045/authors?page=2